Roivant Sciences Ltd

NEW
NAS:ROIV (UK)   Ordinary Shares
$ 10.17 -0.58 (-5.44%) 08:09 PM EST
At Loss
P/B:
1.41
Volume:
6.19M
Avg Vol (2M):
4.29M
Trade In:
Volume:
6.19M
At Loss
Avg Vol (2M):
4.29M

Business Description

Roivant Sciences Ltd

ISIN : BMG762791017

Share Class Description:

ROIV: Ordinary Shares
Description
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
Name Current Vs Industry Vs History
Cash-To-Debt 51.3
Equity-to-Asset 0.9
Debt-to-Equity 0.02
Debt-to-EBITDA 0.02
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 18.74
Distress
Grey
Safe
Beneish M-Score -0.63
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 37.91
Quick Ratio 37.91
Cash Ratio 36.38
Days Inventory 388.91
Days Sales Outstanding 76.13
Days Payable 646.74

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -5.6
Shareholder Yield % 16.08

Financials (Next Earnings Date:2025-05-30 Est.)

ROIV's 30-Y Financials
Income Statement Breakdown FY
Not Enough Data
Balance Sheet Breakdown
Not Enough Data
Cashflow Statement Breakdown
Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
Not Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:ROIV

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016

Roivant Sciences Ltd Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 169.727
EPS (TTM) ($) -0.15
Beta 1.11
3-Year Sharpe Ratio 0.46
3-Year Sortino Ratio 0.92
Volatility % 23.28
14-Day RSI 36.65
14-Day ATR ($) 0.287952
20-Day SMA ($) 10.71175
12-1 Month Momentum % -2.71
52-Week Range ($) 9.76 - 13.055
Shares Outstanding (Mil) 713.55

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Roivant Sciences Ltd Filings

Filing Date Document Date Form
No Filing Data

Roivant Sciences Ltd Stock Events

Financials Calendars
Event Date Price ($)
No Event Data

Roivant Sciences Ltd Frequently Asked Questions

What is Roivant Sciences Ltd(ROIV)'s stock price today?
The current price of ROIV is $10.17. The 52 week high of ROIV is $13.06 and 52 week low is $9.76.
When is next earnings date of Roivant Sciences Ltd(ROIV)?
The next earnings date of Roivant Sciences Ltd(ROIV) is 2025-05-30 Est..
Does Roivant Sciences Ltd(ROIV) pay dividends? If so, how much?
Roivant Sciences Ltd(ROIV) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1